Significance of Elevated Levels of Soluble Factors in the Cerebrospinal Fluid in Patients with, Adult T-cell Leukemia

References

• Uchiyama T., Yodoi J., Sagawa K., Takatsuki K., Uchino H. Adult T-cell leukemia: clinical and hematologic: features of 16 cases. Blood 1977; 50: 481–492
   PubMed Web of Science ®Google Scholar
• Matsumoto M., Nomura K., Matsumoto T., Nishioka K., Hanada S., Furusho H., Kikuchi H., Kato Y., Utsunomiya A., Uematsu T., Iwahashi M., Hashimoto S., Yunoki K. Adult T-cell leukemia-lymphoma in Kagoshima district, southwestern Japan: clinical and hematological characteristics. Jupanese Journal of Clinical Oncology 1979; 9(suppl): 325–336
   Web of Science ®Google Scholar
• Teshima T., Akashi K., Shibuya T., Taniguchi S., Okamura T., Harada M., Sumida I., Hanada M., Niho Y. Central nervous system involvement in adult T-cell leukemia/lymphoma. Cancer 1990; 65: 327–332
   PubMed Web of Science ®Google Scholar
• Borowitz M., Bigner S. H., Johnston W. W. Diagnostic problems in the cytologic evaluation of cerebrospinal fluid for lymphoma and leukemia. Acta Cytologica 1981; 25: 665–674
   PubMed Web of Science ®Google Scholar
• Drewinko B., Sullivan M. P., Martin T. Use of the cry-tocentrifuge in the diagnosis of meningeal leukemia. Cancer 1973; 31: 1331–1336
   PubMed Web of Science ®Google Scholar
• Komp D. M. Diagnosis of CNS leukemia. Amer. J. Pediat. Hematol. Oncol 1979; 1: 31–35
   PubMedGoogle Scholar
• Schold S C., Wasserstrom W. R., Fleisher M., Schwartz M. K., Posner J. B. Cerebrospinal fluid biochemical markers of central nervous system metastases. Annals of Neurology 1980; 8: 597–604
   PubMed Web of Science ®Google Scholar
• Koskiniemi M. Malignancy markers in the cerebrospinal fluid. Eur. J. Pediat. 1988; 148: 3–8
   PubMed Web of Science ®Google Scholar
• Komada Y., Ochiai H., Shimizu K., Azuma E., Kamiya H., Sakurai M. Shedding of CD9 antigen into cerebrospinal fluid by acute lymphoblastic leukemia cells. Blood 1990; 76: 112–116
   PubMed Web of Science ®Google Scholar
• Rombos A., Evangelopoulu-Katsiri E., Mariatos P., Katsouyanni K., Papagegorgiou C. Cerebrospinal fluid carcinoem-bryonic antigen and alphafetoprotein in patients with central nervous system neoplasia. Acta Neurologica Scandinavian 1988; 77: 440–444
   PubMed Web of Science ®Google Scholar
• Rautonen J., Koskiniemi M., Siimes M. A., Salonen E. M., Vaheri A. Elevated cerebrospinal fluid fibronectin concentration at diagnosis indicates poor prognosis in children with acute lymphoblastic leukemia. Internatl. J. Cancer 1989; 43: 32–35
   PubMed Web of Science ®Google Scholar
• Waage A., Halstensen A., Shalaby R., Brandtzaeg P., Kierulf P., Espevik T. Local production of tumor necrosis factor a, interleukin I, and interleukin 6 in meningococcal meningitis, relation to the inflammatory response. J. Exper. Med. 1989; 170: 1859–1867
   PubMed Web of Science ®Google Scholar
• Ohbo K., Sugamura K., Sekizawa T., Kogure K. Interleukin-6 in cerebrospinal fluid of HTLV-I-associated myelopathy. Neurol. 1991; 41: 594–595
   PubMed Web of Science ®Google Scholar
• Symons J. A., McCulloch J. F., Wood N. C., Duff G. W. Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. Clin. Immunol. Immunopathol. 1991; 60: 72–82
   PubMedGoogle Scholar
• Rubin L. A., Nelson D. L. The soluble interleukin-2 receptor: biology, function, and clinical application. Annals Internal Med. 1990; 113: 619–627
   PubMed Web of Science ®Google Scholar
• Yasuda N., Lai P. K., Ip S. H., Kung P. C., Hinuma Y., Matsuoka M., Hattori T., Takatsuki K., Purtilo D. T. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood 1988; 71: 1021–1026
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Chilosi M., Semenzato G. The soluble interleukin-2 receptor in haematological disorders. Brit. J. Haematol. 1987; 67: 377–380
   PubMed Web of Science ®Google Scholar
• Adachi K., Kumamoto T., Araki S. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis. Annals Neurol. 1990; 28: 687–691
   PubMed Web of Science ®Google Scholar
• Kittur S. D., Kittur D. S., Soncrant T. T., Rapoport S. I., Tourtellotte W. W., Nagel J. E., Adler W. H. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders. Annals Neurol. 1990; 28: 1608–173
   Web of Science ®Google Scholar
• Weller M., Stevens A., Sommer N., Schabet M., Wiethölter H. Tumor cell dissemination triggers an intrathecal immune response in neoplastic meningitis. Cancer 1992; 69: 1475–1480
   PubMed Web of Science ®Google Scholar
• Chalon M. P., Sindic C. J., Laterre E. C. Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal. Acta Neurologica Scandinavian 1993; 87: 77–82
   PubMed Web of Science ®Google Scholar
• Hattori T., Uchiyama T., Toibana T., Takatsuki K., Uchino H. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood 1981; 58: 645–647
   PubMed Web of Science ®Google Scholar
• Uchiyama T., Hori T., Tsudo M., Wano Y., Umadome H., Tamori S., Yodoi J., Maeda M., Sawami H., Uchino H. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells. J. Clin. Invest. 1985; 76: 446–453
   PubMed Web of Science ®Google Scholar
• Shimoyama, M. members of the lymphoma study group 1984–87. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia-lymphoma: a report from the lymphoma study group (1984–87). Brit. J. Haematol. 1991; 79: 428–437
   PubMed Web of Science ®Google Scholar
• Uozumi K., Hanada S., Arima T. Elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration. Brit. J. Haematol. 1994; 87: 643–646
   PubMed Web of Science ®Google Scholar
• Uozumi K., Hanada S., Ishitsuka K., Ohno N., Otsuka M., Shimotakahara S., Nakahara K., Takeshita T., Chyuman Y., Kuwazuru Y., Makino T., Saito T., Ishibashi K., Iwahashi M., Utsunomiya A., Arima T. Elevated soluble CD4 levels in the cerebrospinal fluid in patients with adult T-cell leukemia. Am. J. Hematol. 1994; 46: 95–100
   PubMed Web of Science ®Google Scholar
• Rubin L. A., Kurman C. C., Fritz M. E., Biddison W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 1985; 135: 3172–3177
   PubMed Web of Science ®Google Scholar
• Tsukada N., Matsuda M., Miyagi K., Yanagisawa N. Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-I-associated myelopathy. J. Neuroimmunol. 1991; 35: 285–293
   PubMed Web of Science ®Google Scholar
• Shimoda K., Okamura S., Omori F., Mizuno Y., Hara T., Aoki T., Ueda K., Niho Y. Granulocyte colony-stimulating, factor in cerebrospinal fluid from patients with meningitis. Blood 1991; 77: 2214–2217
   PubMed Web of Science ®Google Scholar
• Waage A., Halstensen A., Shalaby R., Brandtzg P., Kierulf P., Espevik T. Local production of tumor necrosis factor α, interleukin I, and interleukin 6 in meningococcal meningitis: relation to the inflammatory response. J. Exper. Med. 1989; 170: 1859–1867
   PubMed Web of Science ®Google Scholar
• Frei K., Leist T. P., Meager A., Gallo P., Leppert D., Zinkernagel R. M., Fontana A. Production of B cell stimulatory factor-2 and interferon γ in the central nervous system during viral meningitis and encephalitis: Evaluation in a murine model infection and in patients. J. Exper. Med. 1988; 168: 449–453
   PubMed Web of Science ®Google Scholar
• Tweardy D. J., Mott P. L., Glazer E. W. Monokine modulation of human astroglial cell production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. I. Effects of IL-1 α and IL-1 β. J. Immunol. 1990; 144: 2233–2241
   PubMed Web of Science ®Google Scholar
• Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A., Donini S. D., Ricciardi-Castagnoli P. Monokine production by microglial cell clones. Eur. J. Immunol. 1989; 19: 1443–1448
   PubMed Web of Science ®Google Scholar
• Frei K., Malipiero U. V., Leist T. P., Zinkernagel R. M., Schwab M. E., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 1989; 19: 689–694
   PubMed Web of Science ®Google Scholar
• Sawada M., Suzumura A., Kondo N., Marunouchi T. Induction of cytokines in glial cells by trans activator of human T-cell lymphotropic virus type I. FEES Lett. 1992; 313: 47–50
   PubMed Web of Science ®Google Scholar
• Ernerudh J., Olsson T., Berlin G., von Schenck H. Cerebrospinal fluid immunoglobulins and β2-microglobulin in lymphoproliferative and other neoplastic diseases of the central nervous system. Arch. Neurol. 1987; 44: 915–920
   PubMed Web of Science ®Google Scholar
• Weller M., Stevens A., Sommer N., Melms A., Dichgans J., Wiethölter H. Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J. Neurological Sci. 1991; 104: 215–221
   PubMed Web of Science ®Google Scholar
• Houssiau F. A., Bukasa K., Sindic C. J. M., van Damme J., van Snick J. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin. and Exper. Immunol. 1988; 71: 320–323
   PubMed Web of Science ®Google Scholar
• Hirohata S., Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis and Rheumatism 1990; 33: 644–649
   PubMed Web of Science ®Google Scholar
• Seki T., Joh K., Oh-Ishi T. Augmented production of interleukin-8 in cerebrospinal fluid in bacterial meningitis. Immunol. 1993; 80: 333–335
   PubMed Web of Science ®Google Scholar
• Ohga S., Aoki T., Okada K., Akeda H., Fujioka K., Ohshima A., Mori T., Minamishima I., Ueda K. Cerebrospinal fluid concentrations of interleukin-I beta, tumor necrosis factor-alpha, and interferon gamma in bacterial meningitis. Archives of Diseases of Child 1994; 70: 123–125
   PubMed Web of Science ®Google Scholar
• Shimoda K., Okamura S., Mizuno Y., Hardda N., Kubota A., Yamada M., Hara T., Aoki Tomonobu, Akeda H., Ueda K., Niho Y. Human macrophage colony-stimulating factor levels in cerebrospinal fluid. Cytokine 1993; 5: 250–254
   PubMed Web of Science ®Google Scholar
• Gallo P., De-Rossi A., Sivieri S., Chieco B. L., Tavolato B. M-CSF production by HIV-1-infected monocytes and its intrathecal synthesis. Implications for neurological HIV-I-related disease. J. Neuroimmunol. 1994; 51: 193–198
   PubMed Web of Science ®Google Scholar
• Sawada S., Sugai S., Iijima S., Takei M., Paredes E., Hayama T., Nishinarita S., Hosokawa Y., Horie T., Obara T. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome. Am. J. Med. 1992; 92: 134–140
   PubMed Web of Science ®Google Scholar
• Takematsu H., Tagami H. Determination of released CD4 andCD8 antigens in the suction-blister fluid and horny-tissue extract in patients with psoriasis. Brit. J. Dermatol. 1991; 124: 550–554
   PubMed Web of Science ®Google Scholar
• Marcon L., Rubin L. A., Kurman C. C., Fritz M. E., Longo D. L., Uchiyama T., Edwards B. K., Nelson D. L. Elevated serum levels of soluble Tac peptide in adult T-cell leukemia: correlation with clinical status during chemotherapy. Annals Int. Med. 1988; 109: 274–279
   PubMed Web of Science ®Google Scholar
• Ambrosetti A., Nadali G., Vinante F., Carlini S., Veneri D., Todeschini G., Morosato L., De Sabata D., Chilosi M., Maggi E., Parronchi P., Romagnani S., Semenzato G., Perona G., Pizzolo G. Serum levels of soluble interleukin-2 receptor in Hodgkin Disease. Relationship with clinical stage, tumor burden, and treatment outcome. Cancer 1993; 72: 201–206
   PubMed Web of Science ®Google Scholar
• Motoi T., Uchiyama T., Hori T., Itoh K., Uchino H., Ueda R. Elevated serum soluble interleukin-2 receptor (Tac antigen) levels in chronic myelogenous leukemia patients with blastic crisis. Blood 1989; 74: 1052–1057
   PubMed Web of Science ®Google Scholar
• Sugimoto M., Nakashima H., Matsumoto M., Uyama E., Ando M., Araki S. Pulmonary involvement in patients with, HTLV-I-associated myelopathy: increased soluble IL-2 receptors in bronchoalveolar lavage fluid. Am. Rev. Respiratory Dis. 1989; 139: 1329–1335
   PubMed Web of Science ®Google Scholar
• Lawrence E. C., Brousseau K. P., Berger M. B., Kurman C. C., Marcon L., Nelson D. L. Elevated concentrations of soluble interleukin-2 receptors in serum samples and bronchoalveolar lavage fluids in active sarcoidosis. Am. Rev. Respiratory Dis. 1988; 137: 759–764
   PubMed Web of Science ®Google Scholar
• Boutin B., Matsuguchi L., Lebon P., Ponsot G., Arthuis M., Nelson D. L. Soluble IL-2 receptors in acute arid subacute encephalitis. Annals of Neurol. 1987; 22: 658–661
   PubMed Web of Science ®Google Scholar
• Greenberg S. J., Marcon L., Hurwitz B. J., Waldmann T. A., Nelson D. L. Elevated levels of soluble interleukin-2 receptors in multiple sclerosis. N. Engl. J. Med. 1988; 319: 1019–1020
   PubMed Web of Science ®Google Scholar
• Olsson T. Cerebrospinal Flui. Annals of Neurol. 1994; 36: s100–s102
   PubMed Web of Science ®Google Scholar